Shares mixed; WiseTech names Murphy as new chair; Star settles tax dispute; ANZ consumer confidence slips; IFM ups Atlas ...
Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results